Management Team
Alison Luckey BM MFPM, Medical Director, Principal Investigator
Jo Kepple RGN MSc, Director Operations
Matt Kepple BPharm MBA, Managing Director
Investigators
Alison Luckey BM MFPM, Medical Director, Principal Investigator
Alison has vocational specialist training in Early Phase Clinical Trials from the Royal College of Physicians, London. She holds the Diploma in Pharmaceutical Medicine, recommended as the primary qualification for conducting phase I trials by the ABPI (Association of the British Pharmacuetical Industry), and is a Member of the Faculty of Pharmaceutical Medicine, Royal College of Physicians, London.
Alison has broad experience in the pharmaceutical industry, having worked as a research physician in specialist phase I units in the UK and New Zealand and as a medical advisor for Solvay Healthcare's (UK) cardiology therapeutic unit. She has also provided medical and scientific support for the clinical research and data management divisions of a medium sized CRO. She has been actively involved with all aspects of Good Clinical Practice, drug development, medical affairs, sales & marketing, regulatory requirements, project management, quality assurance procedures, data management, protocol development, adverse event reporting, ethical committee submission and study report writing.
Previously a health professional member and Deputy Chair of the Upper South A Regional Ethics Committee, and currently a member of the Australian Regulatory and Clinical Scientists Association (ARCS) and a member of the New Zealand Association of Clinical Researchers (NZACRES).
Professor Tim Anderson BSc(Hons), MBChB, MD, FRACP, Principal Investigator
Acting Director, Van der Veer Institute
Professor, Department of Medicine, University of Otago, Christchurch
Neurologist, Department of Neurology, Canterbury District Health Board.
Clinical Operations
Jo Kepple RGN MSc, Director Operations
With over 20 years in healthcare including 16 years in clinical research, Jo's depth and breadth of experience is an invaluable asset to Primorus Clinical Trials. Having managerial positions in both the public health system and blue chip pharma she has an intimate knowledge of Good Clinical Practice and its process from a practical viewpoint and the perspective of the pharmaceutical industry.
Most recently Jo has worked in New Zealand as a consultant providing monitoring, auditing and costing services to the pharmaceutical industry and trials units. Prior to this she was a study team leader in the clinical pharmacology team at Novartis Pharmaceuticals, UK, where she specialised predominantly in phase I trials. She has also worked for a full service international CRO where she had responsibility for monitoring and outsourcing novel compound phase I trials internationally.
Initially training as a registered nurse, Jo has managed the Elton John AIDS Vaccine Clinical Trials Unit at St Mary’s Hospital, London, one of the largest clincial trial units in Europe and set up the day unit for the infectious diseases unit at St Georges Hospital, London. She has also held clinical trial positions for the Medical Research Council (MRC), London and has a Masters degree in Social Research Methodology from Guildhall University in London.
Jo Davis, Research Coordinator
Janeen Williams, Research Nurse
Hayley Foster-Lynam, Administration Assistant
Data Management
Matt Kepple BPharm MBA, Managing Director
With over 20 years experience in the pharmaceutical and healthcare industry, Matt brings to Primorus, a sound understanding of the clinical research sector and a range of technical, marketing and managerial skills. These skills have enabled Primorus to implement a process oriented approach and to introduce innovative solutions to client needs. He has an MBA, focusing on early clinical development and clinical trials, and has worked in clinical research for blue chip pharma.
Matt has worked in the Clinical Research sector as a director and owner of a niche CRO that specialised in bringing outsourced staff into international pharmaceutical companies as team members and virtual employees of those companies. He has also worked in clinical research for Novartis and the CRO, PPD. Prior to this Matt worked as a director and associate director at the multinationals Taylor Nelson Sofres and ISIS Research specialising in the development of data management and modelling software for the pharmaceutical industry. In these positions he was responsible for the management of international sales, marketing and business development in addition to software development programs. He began his career in the pharmaceutical industry in drug information for the pharmaceutical company Glaxo.
Read Donnell, Data Manager, Software Engineer
Biostatistics
Associate Professor Chris Frampton (PhD)
University of Otago (ChCh. School of Medicine and Health Sciences) Assoc. Professor (Biostatistics)
Member of the SCOTT and MARC regulatory committees and provides statistical input into HRC, NHF, and CMRF assessments of funding applications. Chris has worked as a biostatistician for about 20 years, has in excess of 300 refereed publications.